Echocardiographic assessment of the right ventricle in COVID-19: a systematic review

Int J Cardiovasc Imaging. 2021 Dec;37(12):3499-3512. doi: 10.1007/s10554-021-02353-6. Epub 2021 Jul 22.

Abstract

Cardiac involvement has been frequently reported in COVID-19 as responsible of increased morbidity and mortality. Given the importance of right heart function in acute and chronic respiratory diseases, its assessment in SARS-CoV-2 infected patients may add prognostic accuracy. Transthoracic echocardiography has been proposed to early predict myocardial injury and risk of death in hospitalized patients. This systematic review presents the up-to-date sum of literature regarding right ventricle ultrasound assessment. We evaluated commonly used echocardiographic parameters to assess RV function and discussed their relationship with pathophysiological mechanisms involved in COVID-19. We searched Medline and Embase for studies that used transthoracic echocardiography for right ventricle assessment in patients with COVID-19.

Keywords: Echocardiography; Pulmonary hypertension; Right ventricle; SARS-CoV-2.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • COVID-19*
  • Echocardiography
  • Heart Ventricles / diagnostic imaging
  • Humans
  • Predictive Value of Tests
  • SARS-CoV-2
  • Ventricular Dysfunction, Right* / diagnostic imaging
  • Ventricular Dysfunction, Right* / etiology